Concepedia

Harry A. Peters

HA

22

Publications

2.7K

Citations

21

H-Index

1978

Active since

Affiliations

Rotterdam University of Applied Sciences(Current)

Erasmus University Rotterdam

Erasmus MC

Radboud University Nijmegen

Harry A. Peters is an author at Rotterdam University of Applied Sciences specializing in medicine, cancer research, and breast cancer.

Top concepts

Publications per year

1978–2004

22

Publications

22

The urokinase system of plasminogen activation and prognosis in 2780 breast cancer patients.

John A. Foekens, Harry A. Peters, Maxime P. Look et al. · PubMed · 2000 · 429 citations

, , +14

High tumor levels of vascular endothelial growth factor predict poor response to systemic therapy in advanced breast cancer.

John A. Foekens, Harry A. Peters, Nicolaï Grebenchtchikov et al. · PubMed · 2001 · 300 citations

, , +18

Prognostic value of urokinase-type plasminogen activator in 671 primary breast cancer patients.

John A. Foekens, Manfred Schmitt, W L van Putten et al. · PubMed · 1992 · 231 citations

, , +14

Plasminogen activator inhibitor-1 and prognosis in primary breast cancer.

John A. Foekens, Manfred Schmitt, W L van Putten et al. · Journal of Clinical Oncology · 1994 · 225 citations

The MTT Tetrazolium Salt Assay Scrutinized: How to Use this Assay Reliably to Measure Metabolie Activity of Cell Cultures in vitro for the Assessment of Growth Characteristics, IC<sub>50</sub>-Values and Cell Survival

Anieta M. Sieuwerts, Jan G.M. Klijn, Harry A. Peters et al. · Clinical Chemistry and Laboratory Medicine (CCLM) · 1995 · 200 citations · Full text

Rows per page

1–5 of 22